In November Rheumatic Disease Clinics of North America will publish a special issue focusing on “Drug Safety: Managing Innovation in Rheumatology.” This includes invited manuscripts from national experts including WMR faculty, Dr. Richard Martin. WMR has a productive research thread evaluating risk communication related to anti-rheumatic drugs which has been recently received increasing national attention. This is another example of relevant research which translates to improved patient care.
Article synopsis: When proposing a new therapy, rheumatologists must inform patients of a range of therapeutic options and support them towards making an informed decision. These decisions are often made over time and involve multiple stakeholders. This article introduces definitions of equipoise and a good decision, contrast persuasion from informed patient choice, and discuss the effects of patient characteristics including cognition on decision-making. In addition it describes, and offers examples, of techniques and visual formats to present risk estimates to reduce cognitive bias and maximize patient comprehension.
Read more at the National Library of Medicine website